Skip to content

会社情報

The $1,000 Genome

Staggering reduction in cost will help revolutionize medicine

Recent Articles

TruSight Oncology Family Grows with Liquid Biopsy and High-Throughput Assays
TruSight Oncology Family Grows with Liquid Biopsy and High-Throughput Assays
How Sequencing-Based Surveillance Helps Fight COVID-19
How Sequencing-Based Surveillance Helps Fight COVID-19
Illumina Statement on Novel Coronavirus
Illumina Statement on Novel Coronavirus